Matrix metalloproteinases, but not cathepsins B, H, and L or their inhibitors in peripheral blood of patients with rheumatoid arthritis are potentially useful markers of disease activity

Zeitschrift fur Rheumatologie

Volumn 57, Issue 6, 1998, Pages 392-398

  Keyszer, G ^a   Lambin, I ^a   Keysser, M ^b   Keysser, C ^b   Nagel, R ^b   Burmester, G R ^a   Jung, K ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Klinikum Sudstadt   (Germany)

Author keywords

Cysteine proteinases; Matrix metallproteinases; Rheumatoid arthritis; Surrogate markers

Indexed keywords

BIOCHEMICAL MARKER; CATHEPSIN B; CATHEPSIN H; CATHEPSIN L; COLLAGENASE; CYSTEINE PROTEINASE; MATRIX METALLOPROTEINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; AGED; ARTHRITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUOROMETRY; HUMAN; MALE; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS;

AGED; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CATHEPSIN B; CATHEPSINS; COLLAGENASES; CYSTATINS; CYSTEINE ENDOPEPTIDASES; DISEASE PROGRESSION; ENDOPEPTIDASES; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 0344026293     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003930050131     Document Type: Article

References (34)

1. Abrahamson M, Olafsson I, Palsdottir A, Ulvsback M, Lundwall A, Jensson O, Grubb A (1990) Structure and expression of the human cystatin C gene. Biochem J 268:287-294
2. Arnett FC, Edworthy SM, Bloch DA (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 21:315-324
3. Barrett AJ, Kirschke H (1981) Cathepsin B, Cathepsin H, and cathepsin L. Methods Enzymol 80 Pt C:535-561
4. Baumgrass R, Williamson MK, Price PA (1997) Identification of peptide fragments generated by digestion of bovine and human osteocalcin with the lysosomal proteinases cathepsin B, D, L, H, and S. J Bone Miner Res 12:447-455
5. Clark IM, Powell LK, Ramsey S, Hazleman BL, Cawstone TE (1993) The measurement of collagenase, tissue inhibitor of metallproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 36:372-379
6. Duffy JM, Walker B, Guthrie D, Grimshaw J, McNally G, Grimshaw JT, Spedding PL, Mollan RA (1994) The detection, quantification and partial characterisation of cathepsin B-like activity in humam pathological syovial fluids. Eur J Clin Chem Clin Biochem 32: 429-434
7. Eeckhout C, Vaes G (1977) Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Effects of lysosomal cathepsin B, plasmin and kallikrein, and spontaneous activation. Biochem J 166:21-31
8. Esser RE, Angelo RA, Murphey MD, Watts LM, Thornburg LP, Palmer JT, Talhouk AS, Smith RE (1994) Cysteine proteinase inhibitors decrease articular cartilage and bone destruction in chronic inflammatory arthritis. Arthritis Rheum 37:236-247
9. Esser RE, Watts LM, Angelo RA, Thornburg LP, Prior JJ, Palmer JT (1993) The effects of fluoromethyl ketone inhibitors of cathepsin B on adjuvant induced arthritis. J Rheumatol 20: 1176-1183
10. Fassbender HG, Gay S (1988) Synovial processes in rheumatoid arthritis. Scand J Rheumatol Suppl 76:1-7
11. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, Katz LM, Lightfoot R Jr., Paulus H, Strand V et al (1995) American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 38:727-735
12. Gabrijelcic D, Annan-Prah A, Rodic B, Rozman B, Cotic V, Turk V (1990) Determination of cathepsins B and H in sera and synovial fluids of patients with different joint diseases. J Clin Chem Clin Biochem 28:149-153
13. Huet G, Flipo RM, Colin C, Janin A, Hemon B, Collyn M, Lafyatis R, Dequesnoy B, Degand P (1993) Stimulation of the secretion of latent cysteine proteinase activity by tumor necrosis factor alpha and interleukin-1. Arthritis Rheum 36:772-780
14. Ishiguro N, Ito T, Obata K, Fujimoto N, Iwata H (1996) Determination of stromelysin-1, 72 and 92 kDa type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-2 in synovial fluid and serum from patients with rheumatoid arthritis. J Rheumatol 23: 1599-1604
15. Iwata Y, Mort JS, Tateishi H, Lee ER (1997) Macrophage cathepsin L, a factor in the erosion of subchondral bone in rheumatoid arthritis. Arthritis Rheum 40:499-509
16. Keyszer G, Herr AH, Gay S (1994) Cytokines and oncogenes in cellular interactions of rheumatoid arthritis. Stem Cells 12:75-86
17. Keyszer G, Limbiri I, Nagel R, Keysser C. Keysser M, Gromnica-Ihle E, Franz J, Burmester GR, Jung K: Circulating levels of matrix-metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases-1 (TIMP-1) and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis in comparison to other surrogate markers. J Rheumatol (accepted for publication)
18. Keyszer G, Redlich A, Häupl T, Zacher J, Sparmann M, Ungethüm U, Gay S, Burmester GR (1998) Differenlial expression of cathepsins B and L compared to metalloproteinases and their respective inhibitors in rheumatoid arthritis and osteoarthritis. A parallel investigation by semiquantitative RT-PCR and immunohistochemistry. Arthritis Rheum 41:1378-1387
19. Lafyatis R, Remmers EF, Roberts AB, Yocum DE, Spron MB, Wilder RL (1989) Anchorage-independent growth of synoviocytes from arthritic and normal joints. Stimulation of exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids. J Clin Invest 83: 1267-1276
20. Lein M, Nowak L, Jung J, Koenig F, Lichtinghagen R, Schnorr D, Loening SA (1997) Analytical aspects regarding the measurement of metalloproteinases and their inhibitors in blood. Clin Biochem 30:491-496
21. Lemaire R, Huet G, Zerimech F, Grard G, Fontaine C, Dequesnoy B, Flipo RM (1997) Selective induction of the secretion of cathepsin B and L by cytokines in synovial fibroblast-like cells. Brit J Rheum 36:735-743
22. Leto G, Tumminello FM, Montalto G, Soresi M, Gebbia N (1997) Lysosomal cathepsins B and L and Stefin A blood levels in patients with hepatocellular carcinoma and/or liver cirrhosis: Potential clinical implications. Oncology 54:79-83
23. Manicourt DH, Fujimoto N, Obata K, Thonar FJ (1995) Levels of circulating collagenase, stromelysin-1, and tissue inhibitor of matrix metalloproteinases 1 in patients with rheumatoid arthritis. Relationship to serum levels of antigenic keratan sulfate and systemic parameters of inflammation. Arthritis Rheum 38: 1031-1039
24. Mort JS, Recklies AD, Poole AR (1984) Extracellular presence of the lysosomal proteinase cathepsin B in rheumatoid synovium and its activity at neutral pH. Arthritis Rheum 27:509-515
25. Muller-Esterl W, Fritz H, Kellermann J, Lottspeich F, Machleidt W, Turk V (1985) Genealogy of mammalian cysteine proteinase inhibitors. Common evolutionary origin of stefins, cystatins and kininogens. FEBS Lett 191:221-226
26. Murphy G, Ward R, Gavrilovic J, Atkinson S (1992) Physiological mechanisms for metalloproteinase activation. Matrix Suppl 1:224-230
27. Nguyen Q, Mort JS, Roughley PJ (1990) Cartilage proteoglycan aggregate is degraded more extensively by cathepsin L than by cathepsin B. Biochem J 266:569-573
28. Roughley PJ, Barrett AJ (1977) The degradation of cartilage proteoglycans by tissue proteinases: Proteoglycan structure and its susceptibility to proteolysis. Biochem J 167:629-637
29. Schweiger A, Stabuc B, Popovic T, Turk V, Kos J (1997) Enzyme-linked immunosorbant assay for the detection of total cathepsin H in human tissue cytosols and sera. J Immunol Methods 201:165-172
30. Taylor DJ, Cheung NT, Dawes PT (1994) Increased serum proMMP-3 in inflammatory arthritides: A potential indicator of synovial inflammatory monokinc activity. Ann Rheum Dis 53:768-772
31. Trahandt A, Aicher WK, Gay RE, Sukhatme VP, Nilson Hamilton M, Hamilton RT, McGhee JR, Fassbender HG, Gay S (1990) Expression of the collagenolytic and Ras-induced cysteine proteinase cathepsin L and proliferation-associated oncogenes in synovial cells of MRL/I mice and patients with rheumatoid arthritis. Matrix 10:349-361
32. Trabandt A, Gay RE, Fassbender HG, Gay S (1991) Cathepsin B in synovial cells at the site of joint destruction in rheumatoid arthritis. Arthritis Rheum 34:1444-1451
33. Wollheim FA, Eberhardt KB (1992) The search for laboratory measures of outcome in rheumatoid arthritis. Baillieres Clin Rheumatol 6:69-93
34. Yoshihara Y, Obata K, Fujimoto N, Yamashita K, Hayakawa T, Shimmei M (1995) Increased levels of stromelysin-1 and tissue inhibitor of metalloproteinases-1 in sera from patients with rheumatoid arthritis. Arthritis Rheum 38: 969-975